サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597166

北米の臨床リファレンスラボ市場：2031年までの予測 - 地域別分析 - サービスプロバイダー別、用途別

North America Clinical Reference Laboratory Market Forecast to 2031 - Regional Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)

出版日
ページ情報
英文 103 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
北米の臨床リファレンスラボ市場：2031年までの予測 - 地域別分析 - サービスプロバイダー別、用途別
出版日: 2024年10月03日
発行: The Insight Partners
ページ情報: 英文 103 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の臨床リファレンスラボ市場は、2023年に175億7,005万米ドルとなり、2031年までには291億442万米ドルに達すると予測され、2023年から2031年までのCAGRは6.5%と推定されます。

慢性疾患と感染症の有病率の増加が北米の臨床リファレンスラボ市場を活性化

慢性疾患の有病率の増加と様々な感染症の出現と発生は、新規治療オプションと新しい治療カテゴリーへの需要を煽り、既存の治療カテゴリーにおけるより良い治療オプションへのニーズを生み出しています。2023年9月に発表されたWHOのデータによると、心臓病、がん、脳卒中、糖尿病、慢性肺疾患などの非感染性疾患（NCDs）により、毎年4,100万人が死亡しています。United Health Foundationによると、2022年には米国の成人2,900万人以上が3つ以上の慢性疾患を抱えていると報告されています。正確な診断は、特にがんや結核において、疾患のバイオマーカーを特定し、生物を検出するために不可欠です。臨床リファレンスラボは現代のヘルスケアにおいて重要な役割を果たしています。基準検査室は、豚インフルエンザ、A型肝炎、B型肝炎など、専門的な検査機器や専門知識を必要とする感染症の迅速診断のためのサービスを提供しています。また、これらの検査室は、がん、糖尿病、心血管疾患などの一般的な慢性疾患の診断検査を低コストで提供しています。COVID-19パンデミックの際、医療レファレンスラボは迅速な検査、新しい技術の確立、データの作成と分析、知識のハブとしての役割を果たすために不可欠であることが明らかになりました。レファレンスラボは単なる大量検査施設ではなく、専門知識とデータのハブなのです。したがって、感染症や慢性疾患の有病率の上昇が臨床リファレンスラボ市場の成長を促進しています。

北米の臨床リファレンスラボ市場概要

米国は主要な臨床研究地の一つです。臨床試験全体の半分近くが米国で実施されています。また、ほとんどの製薬研究会社は、迅速な承認スケジュール、有利な規制枠組み、確立された医療インフラにより、米国での臨床試験の実施を選択しています。さらに、米国での臨床試験で作成されたデータは世界的に受け入れられています。2021年の世界保健機関（WHO）の報告書によると、米国は最も多くの臨床試験（15万7,618件）を登録しました。

M&Aによる企業参入の拡大は、米国の臨床リファレンスラボ市場の成長をさらに後押しします。例えば、2020年12月、米国の非上場臨床検査機関であるClinical Reference Laboratory（CRL）は、包括的なスクリーニングツールとソリューションの大手プロバイダーであるConfirm BioSciencesを買収しました。CRLは現在の社名のまま子会社として存続します。この買収により、Confirmは臨床検査サービスと研究開発能力へのアクセスを拡大します。NCEZID laboratories、Mayo Clinic Laboratories、CRLは臨床試験における主要なリファレンスラボのひとつです。米国では臨床試験の数が増加しており、同国の臨床リファレンスラボ市場の成長に有利です。

北米の臨床リファレンスラボ市場セグメンテーション

北米の臨床リファレンスラボ市場は、サービスプロバイダー、用途、国に分類されます。

サービスプロバイダーに基づき、北米の臨床リファレンスラボ市場は病院ベース、スタンドアロン、クリニックベースに区分されます。病院ベースのセグメントが2023年に最大の市場シェアを占めました。

用途別では、北米の臨床リファレンスラボ市場は検査室医療、臨床試験、その他に分類されます。2023年には臨床検査部門が最大の市場シェアを占めました。

国別では、北米の臨床リファレンスラボ市場は米国、カナダ、メキシコに区分されます。2023年の北米の臨床リファレンスラボ市場シェアは米国が独占しました。

Sonic Healthcare Ltd、Laboratory Corp of America Holdings、Quest Diagnostics Inc、ARUP Laboratories Inc、Clinical Reference Laboratory Inc、SYNLAB International GmbH、Myraid Genetics Inc、Boca Biolistics LLC、TOPLABは、北米の臨床リファレンスラボ市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 北米の主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の臨床リファレンスラボ市場：主な市場力学

  • 市場促進要因
    • 慢性疾患・感染症の有病率の上昇
    • 臨床試験数の増加
  • 市場抑制要因
    • 規制の枠組みや継続的な技術開発の採用に関する複雑さ
  • 市場機会
    • リファレンスラボとの戦略的イニシアティブ
  • 今後の動向
    • 臨床リファレンスラボにおける人工知能の利用
  • 促進要因と抑制要因の影響

第5章 臨床リファレンスラボ市場：北米分析

  • 臨床レファレンスラボ市場の収益、2021年～2031年
  • 臨床リファレンスラボ市場の予測・分析

第6章 北米の臨床リファレンスラボ市場分析：サービスプロバイダー別

  • 病院ベース
  • 独立型
  • 臨床ベース

第7章 北米の臨床リファレンスラボ市場分析：用途別

  • 臨床検査
  • 臨床試験
  • その他

第8章 北米の臨床リファレンスラボ市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第9章 臨床リファレンスラボ市場：業界情勢

  • 臨床リファレンスラボ市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第10章 企業プロファイル

  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • ARUP Laboratories Inc
  • Clinical Reference Laboratory Inc
  • SYNLAB International GmbH
  • Myraid Genetics Inc
  • Boca Biolistics LLC
  • TOPLAB

第11章 付録

図表

List Of Tables

  • Table 1. North America Clinical Reference Laboratory Market Segmentation
  • Table 2. Clinical Reference Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 4. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 6. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 7. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Service Provider
  • Table 8. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. Recent Inorganic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 10. Recent Organic Growth Strategies in the Clinical Reference Laboratory Market
  • Table 11. Glossary of Terms

List Of Figures

  • Figure 1. North America Clinical Reference Laboratory Market Segmentation, by Country
  • Figure 2. Clinical Reference Laboratory Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • Figure 5. Clinical Reference Laboratory Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 6. Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Clinical-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Clinical Reference Laboratory Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. North America: Clinical Reference Laboratory Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 14. North America: Clinical Reference Laboratory Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 15. US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Growth Strategies in the Clinical Reference Laboratory Market
目次
Product Code: BMIRE00030831

The North America clinical reference laboratory market was valued at US$ 17,570.05 million in 2023 and is expected to reach US$ 29,104.42 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031.

Rising Prevalence of Chronic and Infectious Diseases Fuels North America Clinical Reference Laboratory Market

The increasing prevalence of chronic diseases and the emergence and outbreak of various infectious diseases have fueled the demand for novel treatment options and newer therapeutic categories and created the need for better treatment options in existing therapeutic categories. According to the WHO data released in September 2023, noncommunicable diseases (NCDs), including heart disease, cancer, stroke, diabetes, and chronic lung disease, kill 41 million people each year. According to the United Health Foundation, more than 29 million US adults reported having three or more chronic conditions in 2022. Accurate diagnostics are critical for identifying disease biomarkers and detecting organisms, particularly in cancer and tuberculosis. Clinical reference laboratories play an important role in modern healthcare. The reference laboratories provide services for the quick diagnosis of infectious diseases that require specialized laboratory testing equipment and expertise, such as swine flu, hepatitis A and B. These laboratories also offer low-cost diagnostic testing for common chronic conditions such as cancer, diabetes, and cardiovascular disease. During the COVID-19 pandemic, it became evident that medical reference labs are critical for rapid testing, establishing novel techniques, generating and analyzing data, and serving as knowledge hubs. Reference labs are more than just high-volume testing facilities; they are the hubs of expertise and data. Thus, the rising prevalence of infectious and chronic diseases is driving the growth of the clinical reference laboratory market.

North America Clinical Reference Laboratory Market Overview

The US is one of the leading clinical research destinations. Nearly half of the total clinical trials are performed in the US. Additionally, most pharmaceutical research companies choose to perform clinical trials in the US owing to fast approval timelines, a favorable regulatory framework, and established medical infrastructure. Moreover, data generated for clinical trials in the US is accepted globally. According to the World Health Organization (WHO) report in 2021, the US registered the highest number of clinical trials (157,618).

The expanding access of companies through mergers and acquisitions further boosts the growth of the clinical reference laboratory market in the US. For instance, in December 2020, Clinical Reference Laboratory (CRL)-a privately held clinical testing laboratory in the US-acquired Confirm BioSciences, a leading provider of comprehensive screening tools and solutions. Confirm will continue as a subsidiary under its current name. The acquisition expands Confirm's access to lab testing services and R&D capabilities. NCEZID laboratories, Mayo Clinic Laboratories, and CRL are among the leading reference laboratories for clinical trials. The growing number of clinical trials in the US favors the growth of the clinical reference laboratory market in the country.

North America Clinical Reference Laboratory Market Segmentation

The North America clinical reference laboratory market is categorized into service provider, application, and country.

Based on service provider, the North America clinical reference laboratory market is segmented into hospital-based, standalone, and clinic-based. The hospital-based segment held the largest market share in 2023.

In terms of application, the North America clinical reference laboratory market is categorized into laboratory medicine, clinical trials, and others. The laboratory medicine segment held the largest market share in 2023.

By country, the North America clinical reference laboratory market is segmented into the US, Canada, and Mexico. The US dominated the North America clinical reference laboratory market share in 2023.

Sonic Healthcare Ltd, Laboratory Corp of America Holdings, Quest Diagnostics Inc, ARUP Laboratories Inc, Clinical Reference Laboratory Inc, SYNLAB International GmbH, Myraid Genetics Inc, Boca Biolistics LLC, and TOPLAB are some of the leading companies operating in the North America clinical reference laboratory market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 North America Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Clinical Reference Laboratory Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Chronic and Infectious Diseases
    • 4.1.2 Increasing Number of Clinical Trials
  • 4.2 Market Restraints
    • 4.2.1 Complications Related to Regulatory Framework and Adoption of Continuous Technological Developments
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives with Reference Laboratories
  • 4.4 Future Trends
    • 4.4.1 Use of Artificial Intelligence in Clinical Reference Laboratories
  • 4.5 Impact of Drivers and Restraints:

5. Clinical Reference Laboratory Market - North America Analysis

  • 5.1 Clinical Reference Laboratory Market Revenue (US$ Million), 2021-2031
  • 5.2 Clinical Reference Market Forecast and Analysis

6. North America Clinical Reference Laboratory Market Analysis - by Service Provider

  • 6.1 Overview
  • 6.2 Hospital-Based
    • 6.2.1 Overview
    • 6.2.2 Hospital-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Standalone
    • 6.3.1 Overview
    • 6.3.2 Standalone: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Clinical Based
    • 6.4.1 Overview
    • 6.4.2 Clinical-Based: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Clinical Reference Laboratory Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Laboratory Medicine
    • 7.2.1 Overview
    • 7.2.2 Laboratory Medicine: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Clinical Trials
    • 7.3.1 Overview
    • 7.3.2 Clinical Trials: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Clinical Reference Laboratory Market - Country Analysis

  • 8.1 North America
    • 8.1.1 North America: Clinical Reference Laboratory Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 8.1.1.1 US: Clinical Reference Laboratory Market - Overview
      • 8.1.1.2 US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 US: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.2.2 US: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.3 Canada: Clinical Reference Laboratory Market - Overview
      • 8.1.1.4 Canada: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Canada: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.4.2 Canada: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application
      • 8.1.1.5 Mexico: Clinical Reference Laboratory Market - Overview
      • 8.1.1.6 Mexico: Clinical Reference Laboratory Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.6.1 Mexico: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Service Provider
        • 8.1.1.6.2 Mexico: Clinical Reference Laboratory Market Revenue and Forecast to 2031 (US$ Million), by Application

9. Clinical Reference Laboratory Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Clinical Reference Laboratory Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Sonic Healthcare Ltd
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Laboratory Corp of America Holdings
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Quest Diagnostics Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 ARUP Laboratories Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Clinical Reference Laboratory Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 SYNLAB International GmbH
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Myraid Genetics Inc
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Boca Biolistics LLC
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 TOPLAB
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms